SCHEMBL5776568

SCHEMBL5776568

CCOP(=O)(Cc1ccc(NC(=O)CCc2cnoc2-c2ccc(Cl)c(Br)c2)cc1)OCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.38
HSD17B10 Q99714 3/20 0.38
MAPK10 P53779 1/20 0.38
BTK Q06187 1/20 0.38
MAPT P10636 7/20 0.37
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
MAPK1 P28482 3/20 0.37
GLA P06280 1/20 0.37
LTA4H P09960 1/20 0.36
EPHX2 P34913 1/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
PTK2 Q05397 1/20 0.36
ENTPD1 P49961 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774530 0.90 BTK (0.38) LMNABTKMAPTMEN1KMT2A
SCHEMBL5773311 0.90 BTK (0.38) LMNAHSD17B10MAPK10BTKMAPT
SCHEMBL5772702 0.89 MEN1 (0.39) LMNABTKMAPTMEN1KMT2A
SCHEMBL5777014 0.88 MEN1 (0.46) LMNABTKMAPTMEN1KMT2A
SCHEMBL5777451 0.88 MEN1 (0.41) LMNAMAPTMEN1KMT2AMAPK1
SCHEMBL5771814 0.87 MAPT (0.40) LMNABTKMAPTMEN1KMT2A
SCHEMBL5773241 0.86 BTK (0.39) LMNABTKMAPTMEN1KMT2A
SCHEMBL5774650 0.85 MAPT (0.48) LMNAHSD17B10MAPTMEN1KMT2A
SCHEMBL5771359 0.85 MEN1 (0.40) LMNABTKMAPTMEN1KMT2A
SCHEMBL5771726 0.84 LTA4H (0.46) LMNAHSD17B10MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR LMNA 2770/4885HSD17B10 305/4885MAPK10 2760/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 LMNA 2605/4885HSD17B10 194/4885MAPK10 3001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.